CD47 was highly expressed in bladder urothelial carcinoma (BLCA), BRCA, CESC, cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD) and ovarian cancer (Figure 1B). This evidence concerns the gene CD47 and cholangiocarcinoma.